Effect of low-level laser therapy on pain and swelling in women with breast cancer-related lymphedema: a systematic review and meta-analysis
- 1.6k Downloads
This study aims to examine literature on effectiveness of low-level laser therapy (LLLT) in reducing limb volume and pain in adults with breast cancer-related lymphedema (BCRL).
PubMed, PEDro, CINAHL, and Cochrane databases were searched using (lymphedema OR edema OR swelling) AND (breast cancer OR mastectomy) AND (laser OR low-level laser therapy OR LLLT OR cold laser). Intervention studies or meta-analyses reporting LLLT for BCRL were included in the search. Pooled effect sizes (ES) and 95 % confidence intervals (CI) were calculated for volume and pain. No limitations were placed on length of follow-up, publication year, or language. Final search was conducted on October 16, 2014.
Nine studies met criteria for inclusion. Within-group pooled ES for volume (six studies) was −0.52 (−0.78, −0.25), representing a 75.7-ml reduction in limb volume after LLLT. Between-group pooled ES for volume (four studies) was −0.62 (−0.97, −0.28), representing a 90.9-ml greater reduction in volume with treatment including LLLT versus not including LLLT. Within-group pooled ES for pain reduction (three studies) was −0.62 (−1.06, −0.19), pain reduction of 13.5 mm (0–100 mm VAS). Between-group pooled ES for pain reduction (two studies) was non-significant at −1.21 (−4.51, 2.10).
Moderate-strength evidence supports LLLT in the management of BCRL, with clinically relevant within-group reductions in volume and pain immediately after conclusion of LLLT treatments. Greater reductions in volume were found with the use of LLLT than in treatments without it.
Implications for Cancer Survivors
LLLT confers clinically meaningful reductions in arm volume and pain in women with BCRL.
KeywordsBreast cancer Lymphedema Pain Low-level laser therapy
The authors wish to thank Felicia F. Ferlin, PT, DPT, and Victoria Deguzman, PT, DPT, for their review and critique of this manuscript. Dr. Smoot is partially supported by the Building Interdisciplinary Research Careers in Women’s Health (BIRCWH) K12, Grant Number K12HD052163 NICHD/NIH, and by the National Center for Advancing Translational Sciences, National Institutes of Health, through UCSF-CTSI Grant Number KL2TR000143.
Conflict of interest
The authors declare no financial conflicts of interest.
- 6.Maiya A, Olivia E, Dibya A. Effect of low energy laser therapy in the management of post-mastectomy lymphoedema. Physiother Sing. 2008;11:2–5.Google Scholar
- 11.Cameron M. Electromagnetic radiation: lasers and light. In: Cameron MH, editor. Physical agents in rehabilitation: from research to practice. 3rd ed. St. Louis: Saunders; 2009.Google Scholar
- 12.Lievens P. The influence of laser-irradiation on the motricity of the lymphatical system and on the wound healing process. In: Proceedings International Congress on Laser in Medicine and Surgery, Bologna, June 26–28, 1985. Monduzzi. 1985:171–4.Google Scholar
- 31.de Godoy JMP, da Silva SH. Prevalence of cellulitis and erysipelas in post-mastectomy patients after breast cancer. Arch Med Sci. 2007;3:249–51.Google Scholar
- 33.Tilley S. Use of laser therapy in the management of lymphoedema. J Lymphoedema. 2009;4(1):39–43.Google Scholar
- 35.Owens DK, Lohr KN, Atkins D, et al. Grading the strength of a body of evidence when comparing medical interventions. In: Agency for healthcare research and quality. Methods guide for comparative effectiveness reviews [posted July 2009]. Rockville, MD. Available at: http://effectivehealthcare.ahrq.gov/healthInfo.cfm?infotype=rr&ProcessID=60.
- 36.OCEBM Levels of Evidence Working Group*. The Oxford levels of evidence 2. Oxford Centre for Evidence-Based Medicine. http://www.cebm.net/index.aspx?o=5653. *OCEBM Levels of Evidence Working Group=Jeremy Howick, Iain Chalmers (James Lind Library), Paul Glasziou, Trish Greenhalgh, Carl Heneghan, Alessandro Liberati, Ivan Moschetti, Bob Phillips, Hazel Thornton, Olive Goddard and Mary Hodgkinson.